AnalystsMatthew KellerMatthew Keller's Stock Forecasts
AnalystsMatthew Keller
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4842 out of 5232 analysts
Average Return
-30.35%
Win Rate
8%1 out of 13
Risk vs Reward
Poor
Good
Matthew Keller's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phio Pharmaceuticals CorpPHIO | +8.93% | $1.12 | $1.22 | 2026-02-09 - 2026-03-31 | Buy |
Matthew Keller Analyst Color
Get additional color on Matthew Keller's coverage of popular stocks
Matthew Keller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Phio Pharmaceuticals CorpPHIO | 2 | Buy | $14.00 | +1,047.54% | Reiterates | 2 months ago |
60 Degrees Pharmaceuticals IncSXTP | 2 | Buy | $24.00 | +1,271.43% | Maintains | 2 months ago |
Inflarx NvIFRX | 2 | Buy | $6.00 | +571.14% | Reiterates | 3 months ago |
Galectin Therapeutics IncGALT | 2 | Buy | $11.00 | +294.27% | Maintains | 3 months ago |
Acurx Pharmaceuticals IncACXP | 2 | Buy | $31.00 | +735.58% | Reiterates | 6 months ago |
Kyntra Bio IncKYNB | 2 | Buy | $43.00 | +534.22% | Reiterates | 6 months ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $18.00 | +158.25% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.